头颈癌诊断后同时性与异时性原发性肺癌的结局
15例同时性肺癌中13例首先接受头颈癌根治性治疗,6例完全缓解、5例死亡、4例带瘤存活;肺癌诊断后中位生存13个月,同时性肺癌有生存更优趋势(15 vs 11个月;p = .11)。
要点
- 同时性肺癌组15例中13例首先接受头颈癌根治性治疗。
- 肺癌诊断后中位生存13个月,同时性组15个月 vs 异时性组11个月(p = .11)。
核心结论
- 对头颈癌患者的第二原发肺癌进行积极的多学科管理可获得可观的长期疾病控制,尤其在同时性肺癌患者中。
主要发现
- 同时性肺癌组15例中13例首先接受头颈癌根治性治疗;6/15完全缓解,5/15死亡,4例带瘤存活。
- 肺癌诊断后中位生存13个月,同时性肺癌有生存更优趋势(15 vs 11个月;p = .11)。
临床怎么用
- 对头颈癌患者的第二原发肺癌可考虑积极的多学科管理,以争取长期疾病控制。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Not-infrequently patients with head and neck cancer are also diagnosed with synchronous lung cancer or metachronous primary lung cancer, which complicates the treatment decisions and prognosis. METHODS: Patients were identified from a database of patients with head and neck cancer with second primary non-small cell lung cancer (NSCLC). RESULTS: Thirty-four eligible patients (15 with synchronous lung cancer and 19 with metachronous lung cancer) were identified. Thirteen of 15 patients with synchronous lung cancer received curative intent treatment for head and neck cancer first. Six of 15 patients were in complete remission, 5 of 15 patients had died, and 4 were alive with progressive disease. Median time between 2 diagnoses was 47 months in the metachronous lung cancer group. Twelve patients had died, 3 were alive with disease, and 4 were lost to follow-up. Median survival from the time of lung cancer diagnosis was 13 months with a trend to better survival with synchronous lung cancer (15 vs 11 months; p = .11). CONCLUSION: Aggressive multidisciplinary management of second primary lung malignancies in patients with head and neck cancer can result in respectable long-term disease control particularly in patients with synchronous lung cancer. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1544-1549, 2017.
引用
- Tamjid B, Phan P, John T, et al. Outcomes for patients with synchronous and metachronous primary lung cancer after diagnosis of head and neck cancer. Head Neck. 2017. PMID: 28593651. doi:10.1002/hed.24751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。